Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized controlled trial is to assess a new analgesia regimen that
includes the addition of genicular never blocks to our current standard regimen of peripheral
nerve blocks, which includes an adductor canal block (ACB) and interspace between the
popliteal artery and capsule of the posterior knee block (IPACK). The main questions it aims
to answer are:
1. Does addition of genicular nerve blocks to standard peripheral block regimen
significantly reduce the mean opioid consumption by 33% in the first 24 hours?
2. Does genicular nerve blocks reduce NRS pain scores?
3. Does genicular nerve blocks facilitate earlier discharge?
4. Does genicular nerve blocks last longer than 24 hours?
5. Does genicular nerve blocks improve pain management?
Eligible patients are those undergoing an anterior cruciate ligament repair at the Hospital
for Special Surgery and participants will be randomized to receive the intervention
(genicular nerve block) or the standard of care.